Silence Therapeutics (SLN) Earnings Date & Reports

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SLN is expected to report earnings to rise 28.82% to -14 cents per share on August 06

Silence Therapeutics SLN Stock Earnings Reports

Q2'26

Est.

$-0.14

Q1'26

Beat

by $0.03

Q4'25

Beat

by $0.11

Q3'25

Beat

by $0.04

Q2'25

Missed

by $0.06

The last earnings report on May 07 showed earnings per share of -10 cents, beating the estimate of -14 cents. With 72.27K shares outstanding, the current market capitalization sits at 150.21M.

View a ticker or compare two or three

Compare

SLN

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for SLN